{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:24:18Z","timestamp":1791149058731,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jhep.2013.03.018","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T06:01:06Z","timestamp":1364364066000},"page":"169-177","source":"Crossref","is-referenced-by-count":152,"title":["Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management"],"prefix":"10.1016","volume":"59","author":[{"given":"Jan","family":"Peveling-Oberhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.03.018_b0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.018_b0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/gut.2009.192088","article-title":"Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes","volume":"59","author":"Durand","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.018_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-116-2-97","article-title":"Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study","volume":"116","author":"Simonetti","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.1995.tb05582.x","article-title":"Clonal B-cell expansions in peripheral blood of HCV infected patients","volume":"90","author":"Franzin","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0025","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1002\/art.20594","article-title":"Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection","volume":"50","author":"Vallat","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2013.03.018_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/157488410791110751","article-title":"Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas","volume":"5","author":"Arcaini","year":"2010","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.jhep.2013.03.018_b0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0040","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin\u2019s lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0050","first-page":"S101","article-title":"The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia","volume":"13","author":"Agnello","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2013.03.018_b0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2013.03.018_b0075","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.018_b0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajh.1101","article-title":"Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France","volume":"67","author":"Hausfater","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcv.2012.03.002","article-title":"Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study","volume":"54","author":"Torres","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2013.03.018_b0090","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20608","article-title":"Non-Hodgkin\u2019s lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection","volume":"41","author":"Duberg","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.018_b0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1055-9965.425.13.3","article-title":"Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women","volume":"13","author":"Morton","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2013.03.018_b0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhep.2013.03.018_b0520","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2013.03.018_b0110","first-page":"631a","article-title":"Hepatitis B and C are associated with Non-Hodgkin Lymphoma: cross-sectional study of the National Inpatient Sample database","volume":"56","author":"Moehlen","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.018_b0115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3892\/ijo_00000618","article-title":"Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?","volume":"36","author":"Libra","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jhep.2013.03.018_b0120","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.018_b0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0135","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2013.03.018_b0525","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.leu.2403443","article-title":"Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas","volume":"18","author":"Kelaidi","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jhep.2013.03.018_b0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004836-200404000-00011","article-title":"Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy","volume":"38","author":"Tursi","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.018_b0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2008.07565.x","article-title":"Pegylated-interferon plus ribavirin for HCV positive indolent non-Hodgkin lymphomas","volume":"145","author":"Mazzaro","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0155","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin\u2019s lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2013.03.018_b0160","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/annonc\/mdp454","article-title":"Subcutaneous \u2018lipoma-like\u2019 B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT","volume":"21","author":"Paulli","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2013.03.018_b0165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.thj.6200408","article-title":"Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment","volume":"5","author":"Iannitto","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.jhep.2013.03.018_b0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4254\/wjh.v3.i11.278","article-title":"Hepatitis C virus-related B cell subtypes in non Hodgkin\u2019s lymphoma","volume":"3","author":"Pellicelli","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0175","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJM200311203492121","article-title":"Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa","volume":"349","author":"Levine","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV positive non-Hodgkin\u2019s lymphoma","volume":"49","author":"La Mura","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0185","doi-asserted-by":"crossref","first-page":"688a","DOI":"10.1182\/blood.V106.11.2447.2447","article-title":"Diffuse B-large cell lymphomas (DBLCL) with hepatitis-C virus (HCV) infection: clinical outcome and preliminary results of a pilot study combining R-CHOP with antiviral therapy","volume":"106","author":"Musto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","article-title":"Impact of treatment-related liver toxicity on the outcome of HCV positive non-Hodgkin\u2019s lymphomas","volume":"85","author":"Arcaini","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0195","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2013.03.018_b0200","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2013.03.018_b0530","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0215","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dld.2010.05.010","article-title":"HCV positive status and hepatitis flares in patients with B-cell non-Hodgkin\u2019s lymphoma treated with rituximab-containing regimens","volume":"43","author":"Marignani","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.018_b0225","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa0807650","article-title":"Telaprevir and peginterferon with or without ribavirin for chronic HCV infection","volume":"360","author":"Hezode","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3851\/IMP2127","article-title":"New antiviral therapies in the management of HCV infection","volume":"17","author":"Farnik","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2013.03.018_b0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrgastro.2011.249","article-title":"Hepatitis C in 2011: a new standard of care and the race towards IFN-free therapy","volume":"9","author":"Hofmann","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0245","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.03.018_b0250","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3748\/wjg.15.2305","article-title":"Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy","volume":"15","author":"Conca","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.018_b0255","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1590-8658(07)80009-0","article-title":"Hepatitis C virus lymphotropism: lessons from a decade of studies","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.018_b0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","article-title":"Pre-malignant and malignant lymphoproliferations in an HCV infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process","volume":"87","author":"De Re","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2013.03.018_b0265","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.03.018_b0270","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.2002.01844.x","article-title":"Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection","volume":"128","author":"Zuckerman","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2013.03.018_b0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.03.018_b0280","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.178.4.1407","article-title":"Functional dissection of the CD21\/CD19\/TAPA-1\/Leu-13 complex of B lymphocytes","volume":"178","author":"Matsumoto","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0285","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.03.018_b0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-0039.2009.01414.x","article-title":"HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin\u2019s lymphoma is related to the type II mixed cryoglobulinemia","volume":"75","author":"De Re","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2013.03.018_b0295","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/1529-0131(200109)44:9<2118::AID-ART364>3.0.CO;2-X","article-title":"Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia","volume":"44","author":"Cacoub","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2013.03.018_b0300","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2013.03.018_b0305","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1099\/0022-1317-81-10-2451","article-title":"Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81","volume":"81","author":"Allander","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2013.03.018_b0310","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0315","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0320","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1\u201369 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0325","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM200301093480219","article-title":"Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia","volume":"348","author":"Hermouet","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0330","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8","article-title":"Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma","volume":"43","author":"De Vita","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2013.03.018_b0335","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood.V96.8.2910","article-title":"Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II","volume":"96","author":"Kitay-Cohen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2008.03.031","article-title":"Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas","volume":"49","author":"Libra","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0345","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0350","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.510310230","article-title":"T(14;18) translocation in chronic hepatitis C virus infection","volume":"31","author":"Zignego","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.018_b0355","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-06-0154","article-title":"Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin\u2019s lymphoma","volume":"12","author":"Feldmann","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2013.03.018_b0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","article-title":"B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection","volume":"46","author":"Fabris","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2013.03.018_b0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation \u2013 the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"Sene","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2013.03.018_b0370","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1136\/ard.2010.132001","article-title":"Surrogate markers of B cell non-Hodgkin\u2019s lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis","volume":"69","author":"Geri","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2013.03.018_b0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"BAFF AND APRIL: a tutorial on B cell survival","volume":"21","author":"Mackay","year":"2003","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jhep.2013.03.018_b0380","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","article-title":"BAFF mediates survival of peripheral immature B lymphocytes","volume":"192","author":"Batten","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0385","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/MCB.01469-07","article-title":"Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system","volume":"28","author":"Basak","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2013.03.018_b0535","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/leu.2012.29","article-title":"Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection","volume":"26","author":"Peveling-Oberhag","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jhep.2013.03.018_b0395","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1541-7786.MCR-09-0291","article-title":"Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target","volume":"8","author":"Nassirpour","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhep.2013.03.018_b0400","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.69.12.8079-8083.1995","article-title":"Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR","volume":"69","author":"Lanford","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.03.018_b0405","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI118485","article-title":"Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells","volume":"97","author":"Lerat","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.03.018_b0410","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1182\/blood.V92.9.3328","article-title":"Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers","volume":"92","author":"Sansonno","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0415","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver","volume":"38","author":"Curry","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.018_b0420","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1093\/emboj\/18.20.5755","article-title":"Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1","volume":"18","author":"Sugawara","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2013.03.018_b0425","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clim.2010.02.002","article-title":"Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients","volume":"135","author":"Ito","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhep.2013.03.018_b0540","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2009.03.061","article-title":"Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins","volume":"137","author":"Machida","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.018_b0435","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0147-9571(02)00038-3","article-title":"Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice","volume":"26","author":"Ishikawa","year":"2003","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.jhep.2013.03.018_b0440","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0445","doi-asserted-by":"crossref","first-page":"167501","DOI":"10.5402\/2011\/167501","article-title":"Hepatitis C virus-related lymphomagenesis in a mouse model","volume":"2011","author":"Tsukiyama-Kohara","year":"2011","journal-title":"ISRN Hematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0450","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.03.018_b0455","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2893.2006.00833.x","article-title":"Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases","volume":"14","author":"Hofmann","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.03.018_b0545","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.03081-12","article-title":"B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes","volume":"87","author":"Tucci","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.03.018_b0465","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2141.2001.02571.x","article-title":"Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment","volume":"112","author":"Patriarca","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0470","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V99.6.2259","article-title":"Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia","volume":"99","author":"Casato","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0475","first-page":"585","article-title":"MALT lymphomas of the salivary glands. Review of the literature apropos of a case in a patient with hepatitis C virus infection","volume":"90","author":"Caramaschi","year":"1999","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0480","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-8652(199611)53:3<209::AID-AJH18>3.0.CO;2-8","article-title":"MALT non-Hodgkin\u2019s lymphoma associated with hepatitis C virus infection treated by interferon alpha","volume":"53","author":"Bauduer","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0485","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1365-2141.2003.04751.x","article-title":"Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma","volume":"124","author":"Pitini","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2013.03.018_b0490","first-page":"288","article-title":"The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection","volume":"14","author":"Moccia","year":"1999","journal-title":"Ann Ital Med Int"},{"key":"10.1016\/j.jhep.2013.03.018_b0495","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2013.03.018_b0500","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10620-009-0902-5","article-title":"Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin","volume":"55","author":"Oda","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2013.03.018_b0505","first-page":"101","article-title":"An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin\u2019s lymphoma previously treated with interferon","volume":"10","author":"Mauro","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jhep.2013.03.018_b0510","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2169\/internalmedicine.51.8404","article-title":"Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection","volume":"51","author":"Takahashi","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jhep.2013.03.018_b0515","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1080\/104281905001028289","article-title":"Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection","volume":"46","author":"Svoboda","year":"2005","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:08:01Z","timestamp":1715130481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0168827813001979"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.03.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}